KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced it will launch the Vantage NXT, the successor to Verasonics’ industry-leading Vantage Research Ultrasound System. The Vantage NXT Research Ultrasound System features a proprietary transceiver design that was specifically engineered to provide the next level of transmit and receive fidelity required for cutting-edge ultrasound research. Researchers will gain access to several enhancements including expanded frequency bandwidth, enhanced arbitrary waveform generation and improved high frequency performance and imaging. Vantage NXT also provides a new integrated help system for improved ease of use.
Verasonics will debut Vantage NXT at the upcoming IEEE International Ultrasonics Symposium September 3-8 in Montreal, Canada in booth 29.
“Over the past 15 years, our team has delivered unparalleled ultrasound technology to the scientific research community,” said Jon K. Daigle, President, and CEO of Verasonics. “The Vantage System is recognized for its superior performance and flexibility enabling researchers and developers to explore and innovate a broad scope of applications in biomedical engineering and materials science.”
“We listened to our customers, and Vantage NXT is the result of several years of dedicated work from our product development teams. Not only does it preserve the flexibility and versatility of the Vantage System programming model that our customers desire, it also delivers enhanced performance and additional software features that will allow for continued advancements in research. We are excited to see where researchers and developers will take this innovative technology.”
Vantage NXT will be commercially available later in 2023.
About Verasonics, Inc.
Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Washington, USA. Verasonics is the leader in research ultrasound and is focused on providing researchers and developers with the most advanced and flexible tools enabling them to develop new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in nearly 40 countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts.